In other cancers, the ERCC1 rs11625 wildtype and heterozygotes have been linked with toxicities after oxaliplatin-based chemotherapy [43], and similar to our findings, improved docetaxel effectiveness has been observed in variant carriers [44]. This evidence concerns the gene ERCC1 and cancer.